期刊文献+

结核杆菌抗原CFP21/MTB12/Rv3881c的HLA限制性细胞毒T淋巴细胞表位预测 被引量:4

Prediction of HLA restricted cytotoxic T lymphocyte epitopes in Mycobecterium tuberculosis CFP21/MTB12/Rv3881c
下载PDF
导出
摘要 目的:预测结核杆菌分泌抗原CFP21/MTB12/Rv3881c的HLA限制性细胞毒性T淋巴细胞(CTL)表位。方法:利用SYFPEITHI、BIMAS和NetCTL方法预测分析抗原CFP21/MTB12/Rv3881c的HLA-A*0201限制性CTL表位,进一步运用NetCTL方法对抗原CFP21/MTB12/Rv3881c的HLA-A其他等位基因和HLA-B限制性CTL表位进行预测分析。结果:初步筛选出3个候选抗原HLA-A*0201限制性CTL优势表位各4条,分别为CFP215-13、13-21、134-142、189-197;MTB1226-34、36-44、40-48、61-69;Rv3881c204-212、207-215、234-242、260-268。得到3个候选抗原HLA-A3和HLA-B7限制性CTL优势表位共21条。结论:初步筛选出抗原CFP21/MTB12/Rv3881c潜在的HLA-A*0201、HLA-A3、HLA-B7限制性表位33条。 Aim:To predict the HLA restricted cytotoxic T lymphocyte(CTL) epitopes in Mycobecterium tuberculosis CFP21/MTB12/Rv3881c.Methods:HLA-A0201 restricted CTL epitopes in CFP21/MTB12/Rv3881c were predicted by SYFPEITHI,BIMAS and NetCTL.The restricted T cell epitopes of HLA-B and the other alleles of HLA-A in CFP21/MTB12/Rv3881c were predicted by NetCTL.Results:Derived from the primary prediction results,the 12 predominant HLA-A0201 restricted T cell epitopes of the three candidates were CFP21 5-13,13-21,134-142,189-197,MTB12 26-34,36-44,40-48,61-69,and Rv3881c 204-212,207-215,234-242,260-268.And 21 predominant HLA-A3,B7 restricted T cell epitopes of the three candidates were also confirmed.Conclusion:Thirty three HLA-A0201,HLA-A3 and HLA-B7 restricted CTL epitopes derived from CFP21/MTB12/Rv3881c were predicted.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2010年第1期78-80,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省杰出人才基金资助项目084200510014
关键词 结核杆菌 CFP21 MTB12 Rv3881c 表位预测 Mycobecterium tuberculosis CFP21 MTB12 Rv3881 c epitope prediction
  • 相关文献

参考文献9

  • 1Grover A, Ahmed MF, Verma I, et al. Expression and purification of the Mycobacterium tuberculosis complex-restricted antigen CFP21 to study its immanoprophylactic potential in mouse model[J]. Protein Exp Purif, 2006, 48(2) :274.
  • 2Lee JS, Son JW, Jung SB, et al. Ex vivo responses for interferon-gamma and proinflammatory cytokine secretion to low-molecular-weight antigen MTB12 of Mycobacterium tuberculosis during human tuberculosis [ J ]. Scand J Immunol, 2006, 64(2) :145.
  • 3Malen H, Softeland T, Wiker HG. Antigen analysis of Mycobacterium tuberculosis H37Rv culture filtrate proteins [J]. Scand J Immunol, 2008, 67(3) :245.
  • 4吴传勇,娄加陶,蒋廷旺,钱,周晔,陈燕,陈波,谷明莉,邓安梅,仲人前.结核杆菌抗原Ag85C的HLA-A*0201限制性CD8^+CTL表位的预测及鉴定[J].第二军医大学学报,2007,28(4):349-354. 被引量:7
  • 5Aoshi T, Nagata T, Suzuki M, et al. Identification of an HLA-A * 0201-restricted T-cell epitope on the MPT51 protein, a major secreted protein derived from Mycobacterium tuberculosis, by MPTS1 overlapping peptide screening[J]. Infect lmmun, 2008, 76(4) :1 565.
  • 6Adams HP, Koziol JA. Prediction of binding to MHC class Imolecules [J]. J Immunol Methods, 1995, 185(2) :181.
  • 7Sud D, Bigbee C, Flynn JL, et al. Contribution of CD8^+ T cells to control of Mycobacterium tuberculosis infection [J]. J Immunol, 2006, 176(7) :4 296.
  • 8Sette A, Sidney J. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism [J]. Immunogenetics, 1999, 50(3/4) :201.
  • 9Kesmir C, Nussbaum AK, Schild H, et al. Prediction of proteasome cleavage motifs by neural networks [ J ]. Protein Eng, 2002, 15(4) :287.

二级参考文献20

  • 1Global Tuberculosis Control:Surveillance,Planning,Finacing.WHO report 2004,Geneva,Switzerland,2004.
  • 2Tuberculosis.WHO Fact Sheet No 104 Revised August 2002.http://www.who.int/mediacentre/factsheets/fs104/en.
  • 3Tracevska T,Jansone I,Baumanis V,et al.Prevalence of Beijing genotype in Latvian multidrug-resistant Mycobacterium tuberculosis isolates[J].Int J Tuberc Lung Dis,2003,7:1097-1103.
  • 4Kaufmann S H.Is the development of new tuberculosis vaccine possible[J]? Nat Med,2000,6:955-960.
  • 5Suzuki M,Aoshi T,Nagata T,et al.Identification of murine H2-Dd-and H2-Ab-restricted T-Cell epitopes on a novel protective antigen,MPT51,of Mycobacterium tuberculosis[J].Infect Immun,2004,72:3829-3837.
  • 6Flynn J L,Chan J.Immunology of tuberculosis[J].Annu Rev Immunol,2001,19:93-129.
  • 7Pathan A A,Wilkinson K A,Wilkinson R J,et al.High frequencies of circulating IFN-gamma-secreting CD8 cytotoxic T cells specific for a novel MHC class Ⅰ-restricted Mycobacterium tuberculosis epitope in M.tuberculosis-infected subjects without disease[J].Eur J Immunol,2000,30:2713-2721.
  • 8Geluk A,van Meijgaarden K E,Franken K L,et al.Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8^+ T cells in HLA-transgenic mice and humans[J].J Immunol,2000,165:6463-6471.
  • 9Smith S M,Brookes R,Klein M R,et al.Human CD8^+ CTL specific for the mycobacterial major secreted antigen 85A[J].J Immunol,2000,165:7088-7095.
  • 10Rammensee H,Bachmann J,Emmerich N P,et al.SYFPEITHI:database for MHC ligands and peptide motifs[J].Immunogenetics,1999,50(3-4):213-219.

共引文献6

同被引文献48

  • 1吴玉章,朱锡华.一种病毒蛋白B细胞表位预测方法的建立[J].科学通报,1994,39(24):2275-2279. 被引量:82
  • 2华树成,迟宝荣,李丹,杨杨.结核免疫及免疫治疗的进展[J].吉林大学学报(医学版),2005,31(6):985-988. 被引量:4
  • 3吴传勇,娄加陶,蒋廷旺,钱,周晔,陈燕,陈波,谷明莉,邓安梅,仲人前.结核杆菌抗原Ag85C的HLA-A*0201限制性CD8^+CTL表位的预测及鉴定[J].第二军医大学学报,2007,28(4):349-354. 被引量:7
  • 4杨曌,王莉.低亲和力CTL表位肽在治疗性肿瘤疫苗中应用的研究[J].现代肿瘤医学,2007,15(7):1007-1009. 被引量:1
  • 5Wang J, Qie Y, Zhang H, et al. PPE protein (Rv3425) from DNA segment RD11 of Mycobaeterium tuberculosis: a novel immunodominant antigen of Myeobacterium tubercu- losis induces bumoral and cellular immune responses in mice[J]. Mierobiol Immunol, 2008, 52(4) :224.
  • 6Siddiqi N, Das R, Pathak N, et al. Mycobacterium tubercu- losis isolate with a distinct genomic identity overexpresses a tap-like efflux pump[J]. Infection,2004,32(2) :109.
  • 7Gupta AK, Chauhan DS, Srivastava K, et al. Estimation of efflux mediated multi-drug resistance and its correlation with expression levels of two major efflux pumps in myco- bacteria[ J]. J Commun Dis ,2006,38 ( 3 ) :246.
  • 8Jiang X, Zhang W, Zhang Y, et al. Assessment of efflux pump gene expression in a clinical isolate Mycobacterium tuberculosis by real-time reverse transcription PCR [ J ]. Microb Drug Resist, 2008, 14( 1 ) :7.
  • 9Farrow MF, Rubin EJ. Function of a mycobacterial major facilitator superfamily pump requires a membrane-associat- ed lipoprotein [ J ]. J Bacteriol,2008,190 ( 5 ) : 1783.
  • 10Larsen MV, Lundegaard C, Lamberth K, et al. Large- scale validation of methods for cytotoxic T-lymphocyte epitope prediction[ J]. BMC Bioinformatics, 2007, 8:424.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部